These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2773772)

  • 1. Influence of UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.
    Hasenfuss G; Holubarsch C; Heiss HW; Just H
    Am Heart J; 1989 Sep; 118(3):512-9. PubMed ID: 2773772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the calcium-sensitizer UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Comparison with nitroprusside.
    Hasenfuss G; Holubarsch C; Heiss HW; Rattert B; Just H
    Basic Res Cardiol; 1989; 84 Suppl 1():225-33. PubMed ID: 2818456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pimobendan on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside.
    Hasenfuss G; Holubarsch C; Heiss HW; Allgeier M; Just H
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S31-5. PubMed ID: 2478789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
    Permanetter B; Sebening H; Busch U; Lutilsky L
    Z Kardiol; 1990 Aug; 79(8):565-72. PubMed ID: 2220013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravenous pimobendan (UDCG 115 BS) on hemodynamics and left ventricular volumes in idiopathic dilative cardiomyopathy.
    Permanetter B; Sebening H; Hartmann F; Baumann G; Lutilsky L
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):803-9. PubMed ID: 2481765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone.
    Hasenfuss G; Holubarsch C; Heiss HW; Meinertz T; Bonzel T; Wais U; Lehmann M; Just H
    Circulation; 1989 Jul; 80(1):51-64. PubMed ID: 2525432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathy.
    Holubarsch C; Hasenfuss G; Heiss WH; Just H
    Am J Cardiol; 1988 Sep; 62(8):104E-107E. PubMed ID: 2970783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy.
    Heiss HW; Hasenfuss G; Holubarsch C; Meinertz T; Just H
    Am J Cardiol; 1987 Aug; 60(5):53C-56C. PubMed ID: 2956869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Herz; 1991 Sep; 16 Spec No 1():298-303. PubMed ID: 1820296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the partial beta-1-adrenoceptor agonist xamoterol on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.
    Thierfelder L; Holubarsch C; Hasenfuss G; Heiss HW; Just H
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):593-9. PubMed ID: 1711626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of enoximone on myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside.
    Hasenfuss G; Holubarsch C; Heiss HW; Meinertz T; Hofmann T; Just H
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S69-74. PubMed ID: 2480489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
    Remme WJ; Kruijssen DA; van Hoogenhuyze DC; Krauss XH; Bartels GL; Storm CJ; de Leeuw PW
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):730-9. PubMed ID: 7532750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute effect of the cardioselective beta-1-partial agonist, Corwin, on ventricular function and myocardial oxygen consumption in patients with dilated cardiomyopathy].
    Amende I; Simon R; Hood WP; Lichtlen PR
    Z Kardiol; 1986 May; 75(5):291-5. PubMed ID: 2874668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of intravenous UD-CG 115 BS (pimobendan) on the cardiovascular system and left ventricular pump function.
    Permanetter B; Sebening H; Hartmann F; Klein G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S36-40. PubMed ID: 2478790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial energetics in dilated cardiomyopathy.
    Thierfelder L; Holubarsch CH; Hasenfuss G; Just HJ
    Clin Cardiol; 1990 Sep; 13(9):649-54. PubMed ID: 1976466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.
    Eichhorn EJ; Bedotto JB; Malloy CR; Hatfield BA; Deitchman D; Brown M; Willard JE; Grayburn PA
    Circulation; 1990 Aug; 82(2):473-83. PubMed ID: 1973638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute and chronic effects of UDCG 115 BS (pimobendan) in patients with advanced myocardial failure].
    Permanetter B; Baumann G; Wirtzfeld A; Günes S; Stinshoff M; Klein G
    Z Kardiol; 1989 May; 78(5):335-42. PubMed ID: 2660451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of afterload reduction and a direct beneficial cardiac effect of nifedipine in congestive cardiomyopathy.
    Percy RF; Bass TA; Conetta DA; Miller AB
    Clin Cardiol; 1989 Aug; 12(8):435-40. PubMed ID: 2766589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hydralazine on pressure-volume and stress-volume relations in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Smucker ML; Sanford CF; Lipscomb KM
    Am J Cardiol; 1985 Oct; 56(10):690-5. PubMed ID: 4050708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.